anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
BACKGROUND: There is only sparse knowledge on the psychological burden of patients who have periprosthetic joint infections. The aim of our study was to assess the need for psychological support following total joint arthroplasty of the hip and knee. A special focus was set on patients who had aseptic and septic complications.
METHODS: A total of 13,976 patients who underwent total hip (n = 6,926) or total knee arthroplasty (n = 7,050) between January 1, 2012 and December 31, 2019 at a single institution were retrospectively evaluated for the postoperative need for a psychological consultation. Data were collected on age, sex, type of surgery, and indications for revision procedures. The need for a psychological consultation was assessed during the daily postoperative visits, which were further coordinated by 2 institutional psychologists.
RESULTS: The average age was 68 years (range, 12 to 100), and there were 63.5% women. The overall rate of psychological consultations was 1.7%. Patients who had a septic indication for revision surgery had an 18.7-fold higher rate of postoperative psychological consultations compared to patients following primary surgery and a 5.4-fold higher rate compared to patients who had an aseptic indication. In detail, this rate was 1.0% in the primary subgroup, compared to 7.7% following revision arthroplasty (P < .001). In the revision subgroup, the rate was 17.9% for septic and 3.3% for aseptic revision arthroplasty cases (P < .001). Postoperative psychological consultations were twice as frequent in women (2.1%) compared to men (1.0%), P < .001.
CONCLUSIONS: The present study raises awareness of the markedly high psychological burden in revision arthroplasty cases, in the view of the high estimated number of unknown cases. There is a significant correlation between periprosthetic joint infectionsand the postoperative need for a psychological consultation, with women being at an even higher risk. Health care providers should aim at offering psychological support for patients who have a septic complication, with affected patients being at risk for psychological stress.
LEVEL OF EVIDENCE: IV.
Nearly 90 clinicians and researchers from around the world attended the first IMPROVE 2022 International Meeting on Pathway-Related Obesity. Delegates attended in person or online from across Europe, Argentina and Israel to hear the latest scientific and clinical developments in hyperphagia and severe, early-onset obesity, and set out a vision of excellence for the future for improving the diagnosis, treatment, and care of patients with melanocortin-4 receptor (MC4R) pathway-related obesity. The meeting co-chair Peter Kühnen, Charité Universitätsmedizin Berlin, Germany, indicated that change was needed with the rapidly increasing prevalence of obesity and the associated complications to improve the understanding of the underlying mechanisms and acknowledge that monogenic forms of obesity can play an important role, providing insights that can be applied to a wider group of patients with obesity. World-leading experts presented the latest research and led discussions on the underlying science of obesity, diagnosis (including clinical and genetic approaches such as the role of defective MC4R signalling), and emerging clinical data and research with targeted pharmacological approaches. The aim of the meeting was to agree on the questions that needed to be addressed in future research and to ensure that optimised diagnostic work-up was used with new genetic testing tools becoming available. This should aid the planning of new evidence-based treatment strategies for the future, as explained by co-chair Martin Wabitsch, Ulm University Medical Center, Germany.
Certain aspects of the present disclosure relate to a method of configuring an application with one or more application features. The method comprises receiving a request to configure the application for use by a user. The method further comprises identifying an objective for the user and identifying classifying information associated with the user, the classifying information including at least one of the objective, interest, ability, demographic information, disease progression information, or medication regimen information of the user. The method further comprises selecting a group of users based on one or more similarities between the user and the group of users. The method further comprises identifying the one or more application features based on the objective of the user and a correlation of each of the plurality of application features with the objective. The method further comprises configuring the application with the one or more application features.
The safety and effectiveness of a single dose and a 3-day regimen of EMEND have been established in pediatric patients 6 months to 17 years for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of HEC and MEC.

Use of EMEND in this age group is supported by evidence from adequate and well-controlled studies of EMEND for injection in adults, with additional safety, efficacy and pharmacokinetic data in pediatric patients 6 months to 17 years. Efficacy and safety were also supported by data from an adequate and well-controlled study of a 3-day oral aprepitant regimen in pediatric patients 6 months to 17 years. The safety of the 3-day EMEND for injection regimen in pediatric patients 6 months to 17 years of age was supported by an open-label study in 100 patients receiving HEC or MEC. See the full prescribing information for EMEND capsules for complete clinical information regarding studies performed with oral aprepitant. Adverse reactions were similar to those reported in adult patients [see Dosage and Administration (2.2), Adverse Reactions (6.1), Clinical Pharmacology (12.3)].

The safety and effectiveness of EMEND for the prevention of nausea and vomiting associated with HEC or MEC have not been established in patients less than 6 months of age.

Juvenile Animal Toxicity Data

In juvenile dogs treated with fosaprepitant, changes in reproductive organs were observed. In juvenile rats treated with aprepitant, slight changes in sexual maturation were observed without an effect on reproduction. No effects on neurobehavior, sensory and motor function, or learning and memory were observed in rats.

In a toxicity study in juvenile dogs treated with fosaprepitant from postnatal day 14 (equivalent to a newborn human) to day 42 (approximately equivalent to a 2 year old human), decreased testicular weight and Leydig cell size were seen in the males at 6 mg/kg/day and increased uterine weight, hypertrophy of the uterus and cervix, and edema of vaginal tissues were seen in females from 4 mg/kg/day. A study was also conducted in young rats to evaluate the effects of aprepitant on growth and on neurobehavioral and sexual development. Rats were treated at oral doses up to the maximum feasible dose of 1000 mg/kg twice daily (providing exposure in male and female rats lower than the exposure at the recommended pediatric human dose) from the early postnatal period (Postnatal Day 10 (equivalent to a newborn human) through Postnatal Day 58 (approximately equivalent to a 15 year old human)). Slight changes in the onset of sexual maturation were observed in female and male rats; however, there were no effects on mating, fertility, embryonic-fetal survival, or histomorphology of the reproductive organs. There were no effects in neurobehavioral tests of sensory function, motor function, and learning and memory.
To provide telomerase containing exosomes for treating diseases associated with aging and age-related organ dysfunction.SOLUTION: Provided herein is a composition of a lipid-based nanoparticle (e.g., exosome) including a therapeutic antiaging agent. Further, a use method of such a composition for treating a patient suffering from an age-related disorder is provided. In particular, provided herein is an exosome comprising an RNA encoding a telomerase, and use methods thereof for treating age-related disorders. In an embodiment, a composition comprising a lipid-based nanoparticle comprising a therapeutic cargo that enhances the activity of telomerase complex is provided. In some aspects, the lipid-based nanoparticle comprises CD47 on its surface. In some aspects, the lipid-based nanoparticle comprises a growth factor on its surface.SELECTED DRAWING: None
Patients do not participate in a formal exercise program for 16 weeks. Patients are then offered the Curves exercise intervention.
The invention discloses a formula of Chinese medicinal herb for treating stomach diseases. According to the formula, the Chinese medicinal herb comprises the following medicaments in part by weight: 15 parts of cuttlebone, 10 parts of rhizoma corydalis, 10 parts of chicken's gizzard-membrane, 8 parts of violet, 10 parts of eucalyptusglobulus labill, 8 parts of liquoric root, 8 parts of bletilla and 6 parts of bamboo shavings. The medicaments are prepared into powder and encapsulated into capsules according to the formula. According to the formula, the Chinese medicinal herb has obvious curative effects on diseases such as various kinds of stomachache, gastrectasia, gastritis, gastric ulcer, gastric ulcer and the like. The Chinese medicinal herb has the following taking methods of: taking three times every day, taking 4g every time, taking with wine before meals, and taking 7 days as a treatment course. The medicament has the advantages of long medicinal effect, good effects of treating the stomach disease, and radical cure.
Surgery is the most used treatment in orthopedics. During orthopedic surgery, the integrity of the skin barrier is compromised, resulting in direct exposure of sterile tissue to the external environment and the potential impact of surgical instruments on local tissue. Additionally, orthopedic surgery procedures often entail prolonged duration, extensive surgical areas, and significant blood loss, all of which contribute to an elevated risk of surgical site infections. However, there are some limitations in the practical application of the conventional nursing model in the operating room. Against this backdrop, numerous new nursing models have emerged to meet contemporary demands. Among them, the integration of medical and nursing staff (MANS) in the operating room has garnered significant attention. Presently, this integrated model is predominantly employed in critical care settings and for postoperative infection prevention. However, the establishment and effectiveness of an integrated working group comprising both MANS in the operating room remains in its nascent stage of exploration, warranting further investigation into its clinical impact and implications.
OBJECTIVES: Acute confusional state (ACS) is a common cause of admission to the emergency department (ED). It can be related to numerous etiologies. Electroencephalography (EEG) can show specific abnormalities in cases of non-convulsive status epilepticus (NCSE), or metabolic or toxic encephalopathy. However, up to 80% of patients with a final diagnosis of NCSE have an ACS initially attributed to another cause. The exact place of EEG in the diagnostic work-up remains unclear.
METHODS: Data of consecutive patients admitted to the ED for an ACS in a two-year period and who were referred for an EEG were collected. The initial working diagnosis was based on medical history, clinical, biological and imaging investigations allowing classification into four diagnostic categories. Comparison to the final diagnosis was performed after EEG recordings (and sometimes additional tests) were performed, which allowed the reclassification of some patients from one category to another.
RESULTS: Seventy-five patients (mean age: 71.1 years) were included with the following suspected diagnoses: seizures for 8 (11%), encephalopathy for 14 (19%), other cause for 34 (45%) and unknown for 19 (25%). EEG was recorded after a mean of 1.5 days after symptom onset, and resulted in the reclassification of patients as follows: seizure for 15 (20%), encephalopathy for 15 (20%), other cause for 29 (39%) and unknown cause for 16 (21%). Moreover, ongoing epileptic activity (NCSE or seizure) and interictal epileptiform activity were found in eight (11%) patients initially diagnosed in another category.
DISCUSSION: In our cohort, EEG was a key examination in the management strategy of ACS in 11% of patients admitted to the ED. It resulted in a diagnosis of epilepsy in these patients admitted with unusual confounding presentations.
Hospitalized COVID-19 patients ages ≥18 years with respiratory symptoms, requiring \>6 L of oxygen to maintain oxygen saturation \>92%. Patient may not require intubation, and may be admitted for no longer than 14 days.
Heat stress-related kidney injury has drawn public health attention. This study explored the temporal relationships between impaired kidney function and preceding outdoor heat exposure Taiwan. Data of participants collected through a health screening program was used to assess the association between chronic kidney disease (CKD) and average ambient temperature with various time lag structures. A total of 1,243 CKD cases and 38,831 non-CKD participants were included in the study. After adjusting for demographic, socioeconomic, lifestyle factors, and comorbidities, CKD was positively associated with the ambient temperature within 1-9 months. The 9-month average ambient temperature yielded the highest odds ratio of CKD (OR = 1.22; 95% CI = 1.09-1.37). Furthermore, females and farmers were found to be more vulnerable to CKD risk after outdoor heat exposure. These findings suggest that the prevention of heat stress-related kidney injury should consider relevant time frames and focus on vulnerable populations.
NEW MATERIAL:The pyrazinylmethane derivative of formula I [R is lower alkanoyl or sulfo (-SO3H)] and its salt. EXAMPLE:Bis(4-acetoxyphenyl)-(2-pyrazinyl)methane. USE:It has excellent cathartic action and is useful as a remedy for various constipations, a post-operative evacuation assistant and an evacuation assistant after the administration of a contrasting agent (barium sulfate). It can be used as a peroral drug or suppository. PREPARATION:The compound of formula I can be produced by reacting a phenol derivative of formula II with a reactive derivative of a carboxylic acid derivative of formula III (R1 is lower alkyl). The reaction temperature is preferably 0-100 deg.C.
After randomization, the enrolled patients in this arm should be completely free from the risk of perioperative complications or recovered from the effects of complications, usually no earlier than 4 weeks after surgery but no more than 10 weeks after surgery, before receiving baseline follow-up and starting oral administration of placebo on the day of baseline follow-up. Patients in the treatment group should take placebo (80 mg each time) orally on an empty stomach before breakfast once a day. The medicine should be taken about the same time each day, by swallowing the whole tablet with water, without crushing or chewing. Patients should maintain oral administration of placebo for 6 consecutive months, unless there is disease progression, death, new anti-tumor therapy received or intolerance of investigational drugs.
Single port appendectomy can be considered as the better option than conventional laparoscopic appendectomy (CLA) for pediatric patients with uncomplicated acute appendicitis in cosmetic aspect. However, this technique has not gained popularity because it has been regarded as a tricky and time-consuming procedure. Recently, the frequency of implementation of transumbilical laparoscopy-assisted appendectomy (TULAA) is increasing in pediatric patients with uncomplicated appendicitis. The reason that this operation is possible in children, is that the length between umbilicus and appendix is shorter than that of an adult, and the abdominal wall is flexible, so that the appendix can be extracted through umbilical incision. It was reported that the operation time was shorter and the postoperative frequency of complications was not high compared to the laparoscopic appendectomy with three conventional ports. The purpose of this study is to evaluate the outcomes of transumbilical laparoscopic-assisted appendectomy (TULAA) and to compare them to the outcomes of CLA.
This study presents a critical analysis of complications following cranioplasty (CP) after decompressive hemicraniectomy, focusing on autologous, polymethylmethacrylate (PMMA), and computer-aided design (CAD) implants. The analysis encompasses a retrospective bicenter assessment, evaluating factors influencing surgical outcomes and emphasizing the significance of material selection in minimizing postoperative complications. The study's comprehensive examination of complication rates associated with various implant materials contributes significantly to understanding CP outcomes. While polymethylmethacrylate (PMMA) and autologous bone flaps (ABFs) exhibited higher rates of surgical site infection (SSI) and explantation, a meta-analysis revealed a contrasting lower infection rate for polyether ether ketone (PEEK) implants. The study underscores the critical role of material selection in mitigating postoperative complications. Despite its strengths, the study's retrospective design, reliance on data from two centers, and limited sample size pose limitations. Future research should prioritize prospective, multicenter studies with standardized protocols to enhance diagnostic accuracy and treatment efficacy in CP procedures.
1. Technical Result Increase in inhibiting capability of tyrosine kinases epidermal growth factor.          2. Essence A compound is presented by the formula wherein R1 – R6, A, B, E, X, Ar, n and m have the values disclosed in the description.          Pharmaceutical composition together with the pharmaceutically acceptable carrier, the solvent and the filler as an active ingredient contains the mentioned compound in the pharmaceutically effective amount.         The method for treatment comprises administering the mentioned compound to mammals in therapeutically effective amount.         3. Field of Application Pharmaco-chemistry, medicine.
BACKGROUND: Obesity is a common disease among Kuwaitis. Multiple types of bariatric procedures are offered in Kuwait. R-Y gastric bypass is among the common surgeries performed. Early and late complications must be recognized as early as possible to avoid undesirable consequences.
CASE PRESENTATION: Here, we present a case of a 48-year-old lady presented as acute abdominal pain and diagnosed as Jejuno-Jejunal anastomosis site ulceration / perforation taking place several years from surgery.
DISCUSSION: Etiology of late perforation can be attributed to ischemia. Computerized tomography (C.T.) scan is the gold standard for diagnosis. Management can be laparoscopic or open surgery depending on surgeon expertise. We performed a laparoscopic resection for the extended perforated jejunal recess and that was enough to resolve our patient's problem.
Gut microbiota refers to the bacterial communities in the gastrointestinal tract. The diversity and quantity of bacteria vary depending on age of the individuals, daily diet and the segment of the intestine, which makes the gut microbiota one of the most complex bacterial ecosystems known to men. In general, over trillions of bacteria reside in human gut. Recent evidence indicates that gut microbiota could be involved in host metabolism by multiple pathways leading to the development of obesity and type 2 diabetes. Increased fat storage or obesity has become one of the leading public health issues in many developed and developing countries. However, it is not clear whether type 2 diabetes is associated with a unique gut microbiota profile. Therefore, the primary objective of the study is to compare the fecal microbiota of overweight type 2 diabetic subjects to that of age, gender and BMI matched subjects as well as with lean non-diabetic subjects. In addition, the investigators hypothesize that microbiota modifications with consumption of fiber rich food products can improve the metabolic outcomes of type 2 diabetics. To test this hypothesis, the investigators plan to provide each overweight participant with two cereal bars per day for 4 weeks. Anthropometric measurements and plasma parameters as well as the fecal microbiota will be determined.
PURPOSE:To obtain a prophylactic and therapeutic agent for cancers, containing a component selected from mugwort, an extract of mugwort with water, an extract of oolong tea with water/an extract of coarse tea with water, Perilla frutescens and an extract of Perilla frutescens with water. CONSTITUTION:This prophylactic and therapeutic agent for cancers contains one or more selected from the group consisting of mugwort, an extract of mugwort with water, an extract of oolong tea with water/an extract of coarse tea with water, Perilla frutescens and an extract of Perilla frutescens with water as an active ingredient. Oolong tea, mugwort, coarse tea and Perilla frutescens generally on the market can be used and mugwort and Perilla frutescens may be used in a raw state as they are and heated (boiled) to increase activity. Oolong tea and coarse tea are extracted with water and oolong tea and coarse tea boiled in boiling water for 10 minutes are better than those allowed to stand in boiling water for 10 minutes in terms of activity. The active ingredient is pharmaceutically manufactured into a dosage form such as a tablet, a capsule, a pack, powder, a granule, a troche or an oral solution. A dose is 100-1,000L calculated as an extracted solution with 1-5 times as much as water daily.
PURPOSE: A composition containing bee venom extract is provided to suppress melanogenesis and to promote filaggrin expression. CONSTITUTION: A composition for skin whitening and moisturizing contains bee venom extract as an active ingredient. The bee venom extract is isolated using water, organic solvent, or mixture thereof. The organic solvent includes methanol, ethanol, isopropyl alcohol, n-propyl alcohol, n-butanol, isobutanol, ether, ethyl acetate, or chloroform. A cosmetic composition contains 0.0001-30 wt% of the composition. The cosmetic composition is manufactured in the form of a skin softener, astringent, nutrition cream, massage cream, essence, eye cream, eye essence, cleansing cream, cleansing lotion, pack, powder, body lotion, body essence, hair essence, hair serum, hair treatment, hair conditioner, hair shampoo, hair lotion, or toothpaste.
Head and neck squamous cell carcinoma (HNSCC) exhibits significant genetic heterogeneity and primarily concerns the oral cavity and oropharynx. These cancers occur more frequently in men with a 5-year survival rate below 50%. Major risk factors include human papilloma virus (HPV) (notably type 16), Epstein-Barr virus, tobacco, alcohol, and poor oral hygiene with approximately 4.5% of global cancers linked to HPV. Notably, differences in the microbiome between healthy individuals and patients with head and neck cancers (HNCs) have been identified. Recent studies highlight the significance of certain oral microbes in risk assessment and the potential of the microbiome as a biomarker for HNCs. Additionally, role of the microbiome in metastasis has been acknowledged. Treatment for HNCs includes local methods, such as surgery and radiotherapy, and systemic approaches, such as immunotherapy. Numerous side effects accompany these treatments. Emerging research suggests the beneficial role of preoperative immunonutrition and probiotics in patient outcomes, emphasizing the influence of the microbiome on treatment efficacy. This review explores the reciprocal effects of HNC treatment and the gut microbiome using radiotherapy, brachytherapy, surgery, immunotherapy, and chemotherapy.
Patients (n = 30) with severe AN, refered to the specialized medical nutrition section at Odense University Hospital are tested three times during nutritional rehabilitation: At admission, at discharge (or drop out) and two-four months after discharge. The first study is carried out not before the third day of hospitalization after acclimatization and water electrolyte correction.